EXDI Exactus Inc

CORRECTION -- Exactus, Inc. Launches a Genetics Division to Supply Farmers with USDA Compliant Feminized CBD and CBG Hemp Seeds

CORRECTION -- Exactus, Inc. Launches a Genetics Division to Supply Farmers with USDA Compliant Feminized CBD and CBG Hemp Seeds

DELRAY BEACH, Fla., April 28, 2020 (GLOBE NEWSWIRE) -- In a release issued under a similar headline today, April 28th by Exactus, Inc. (OTCQB:EXDI), please note that in the headline and opening sentence of the first paragraph, "FDA compliant" has been corrected to "USDA compliant". The corrected release follows:

Exactus, Inc. (OTCQB:EXDI) (the “Company”), a leading producer of hemp and hemp-derived specialty cannabinoid products, announced today that it has launched its to supply farmers with USDA compliant feminized CBD and CBG hemp seeds.

Exactus is proud to expand its product portfolio to become a reliable source for farmers while continuing to provide the industry with the most in-demand hemp-derived specialty ingredients and consumer products, including CBD, CBG, CBN, CBC, and other specialty cannabinoids.

The intention behind Exactus creating a genetics division is that with over 20 years of experience in agriculture the Company is equipped to advise farmers, helping them determine which genetics in the Exactus seed catalog will be superior for each region and farming methodology they are growing in.

This announcement comes just one week after the USDA approved Florida’s hemp plan which several thousand farmers are expected to apply. The Company is anticipating a first to market demand for farmers ready to plant their first hemp crop in Florida, and Exactus is eager to become a trustworthy source of feminized CBD and CBG hemp seeds for these farmers. Because Florida’s climate will allow for year-round hemp cultivation Exactus launching its genetics division comes at an ideal time to begin developing farming partners in their home state.

Exactus Interim CEO Emiliano Aloi was behind the 2016 hemp genetics selection program in partnership with the University of Kentucky during his time at GenCanna. The collaboration started as a consequence of the market needing reliable and compliant genetics sources to help farmers ensure success in growing hemp which at the time was an emerging crop. Exactus’ management team has extensive experience in hemp farming, including a successful harvest in over 200 acres at Exactus One World’s farms in Southwest Oregon and has partnered with some of the best breeders in the industry to supply genetics from proprietary seeds.

“In an effort to further develop our company offering, and through our farming partnerships we are able to provide farmers with a trustworthy source of CBD and CBG hemp genetics, said Derek Du Chesne, Chief Growth Officer of Exactus Inc.” We wanted to create a division that focuses on helping farmers produce this resourceful crop and provide access to consistent and compliant hemp bred specifically for high cannabinoid and terpene profiles.”

Exactus, is providing the industry with certified feminized seeds that deliver farmers confidence that the genetics going into their soil are vetted for quality and will yield a healthy and compliant crop. When a company is purchasing raw materials, they have the advantage of testing those materials with minimal risk, while farmers unfortunately risk losing an entire crop, so it's important that they are purchasing genetics from a dependable source, and Exactus can provide that for them ensuring the use of certified feminized genetics that have successfully been farmed in the past.

To learn more about Exactus, Inc., visit the website at .

About Exactus, Inc.

Exactus Inc. (OTCQB:EXDI) is a leading producer of hemp and hemp-derived products that is committed to creating a positive impact on society and the environment through sustainable agricultural practices.  Exactus is redefining the hemp-industry by having invested in the research and development of specialty cannabinoids and continues to stay ahead of market trends and regulations. We take pride in pioneering the hemp industry by providing raw materials and white-label CBD/CBG products to popular mainstream consumer brands.  The company is at the forefront of product development for the food and beverage, pharmaceutical, cosmetics, beauty, personal care, pet and industries.

Investor Contact:

Andrew Johnson

Chief Strategy Officer

Exactus Inc.

PR Contact:

Kathleen Gonzales

EN
28/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Exactus Inc

 PRESS RELEASE

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Confer...

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Conference Call Second Quarter 2020 Highlights Total Net Revenue of $531,240Continuation of Sales & Marketing BuildoutWhite Label Division LaunchEuropean Sales ExpansionStrengthened the Balance Sheet DELRAY BEACH, Fla., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, reported its financial results for the second quarter 2020 and conference call dial-in information. During the second quarter of 2020, Exactus c...

 PRESS RELEASE

Exactus, Inc. Reports First Quarter 2020 Financial Results

Exactus, Inc. Reports First Quarter 2020 Financial Results First Quarter 2020 Highlights Total Net Revenue of $836,000Continuation of Sales & Marketing BuildoutRestructuring of Company and Board of DirectorsBegan Biomass Inventory Extraction ProcessDuring Q2 2020, The Company Received PPP Funds and an SBA Loan DELRAY BEACH, Fla., July 01, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the first quarter 2020. During the first quarter of 2020, E...

 PRESS RELEASE

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of...

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of the Board of Directors DELRAY BEACH, Fla., June 15, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the appointment of executive business leader, Julian Pittam to the Chairman of the Board. “Julian Pittam has been an investor and a friendly voice of wisdom since our inception, and we are honored to have him join as Chairman of the Board at this pivotal moment,” said Emiliano Aloi, Exactus Interim Chie...

 PRESS RELEASE

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impa...

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic DELRAY BEACH, Fla., May 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the institution of its Exactus Hemp Buyback Program in support of farmers who purchase seeds from the company. Exactus introduced its buyback program during this essential hemp planting season to aid farmers faced with hardships caused by the COVID-19 pandemic. With the launch of its buyback progra...

 PRESS RELEASE

Exactus, Inc. Reports 2019 Year End Results

Exactus, Inc. Reports 2019 Year End Results Year End 2019 Highlights Completed first harvestEntered into multiple supply agreements with industry leadersBuilt a foundation for mainstream adoptionSolidified our footprint in the hemp industryDuring Q1 2020, purchase orders for approximately $900,000 of CBD and CBG products have been received. DELRAY BEACH, Fla., May 26, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the year end 2019. Duri...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch